{"id":9423,"date":"2021-12-02T19:57:36","date_gmt":"2021-12-02T19:57:36","guid":{"rendered":"http:\/\/cvx.vc\/?p=9423"},"modified":"2021-12-02T19:57:36","modified_gmt":"2021-12-02T19:57:36","slug":"dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/","title":{"rendered":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab"},"content":{"rendered":"<p>V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme. Det ville sige, at BioTech-kometen arbejder med l\u00e6gemidler, der kan forhindre u\u00f8nsket v\u00e6gttab.<\/p>\n<p><em>&#8220;I \u00f8jeblikket er vi p\u00e5 vej mod at indfri vores udviklingsm\u00e5l, som er at identificere og karakterisere en hovedkandidat inden for en tidsramme p\u00e5 12-18 m\u00e5neder fra i dag,&#8221;<\/em> udtaler Keld Fosgerau, medstifter og adm. direkt\u00f8r hos Pephexia, i en pressemeddelelse.<\/p>\n<p>Pephexia blev stiftet i 2020 af Keld Fosgerau og besk\u00e6ftiger i dag fem medarbejdere. Nu skal virksomheden bruge den nye kapital til at forts\u00e6tte arbejdet og udviklingen af l\u00e6gemidlet med m\u00e5ls\u00e6tningen om klinkisk godkendelse.<\/p>\n<p>L\u00e6s hele artiklen p\u00e5 MedWatch <em><a href=\"https:\/\/medwatch.dk\/Medicinal___Biotek\/article13515920.ece\"><strong>her<\/strong><\/a><\/em>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.<\/p>\n","protected":false},"author":25,"featured_media":9426,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab | CVX Ventures<\/title>\n<meta name=\"description\" content=\"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab\" \/>\n<meta property=\"og:description\" content=\"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T19:57:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab\",\"datePublished\":\"2021-12-02T19:57:36+00:00\",\"dateModified\":\"2021-12-02T19:57:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\"},\"wordCount\":153,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\",\"name\":\"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg\",\"datePublished\":\"2021-12-02T19:57:36+00:00\",\"dateModified\":\"2021-12-02T19:57:36+00:00\",\"description\":\"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg\",\"width\":2048,\"height\":1536},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab | CVX Ventures","description":"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/","og_locale":"da_DK","og_type":"article","og_title":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab","og_description":"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.","og_url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2021-12-02T19:57:36+00:00","og_image":[{"width":2048,"height":1536,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg","type":"image\/jpeg"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab","datePublished":"2021-12-02T19:57:36+00:00","dateModified":"2021-12-02T19:57:36+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/"},"wordCount":153,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/","url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/","name":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg","datePublished":"2021-12-02T19:57:36+00:00","dateModified":"2021-12-02T19:57:36+00:00","description":"V\u00e6kstkometen Pephexia har rejst 3 mio. kr. i form af et konvertibelt l\u00e5n fra V\u00e6kstfonden. Virksomheden arbejder p\u00e5 udvikling af nye peptid-baserede farmakok\u00e9er for en effektiv behandling af kakeksi, sarcopenia, og relaterede sygdomme.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/12\/aW328vkC.jpeg","width":2048,"height":1536},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-lander-millioninvestering-udvikler-laegemiddel-mod-uonsket-vaegttab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Dansk BioTech-komet lander millioninvestering: Udvikler l\u00e6gemiddel mod u\u00f8nsket v\u00e6gttab"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9423"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=9423"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9423\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/9426"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=9423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=9423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=9423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}